Sanolium AB interim report, January - March 2022
Revenue in the first quarter amounted to 205.3 (206.7) MSEK, representing a decrease of -0.7%Revenue in the first quarter amounted to 205.3 (206.7) MSEK, representing a decrease of -0.7%. Support and maintenance fees constitute the largest share of the revenue. License revenue and Professional Services revenue are attributable to the development of the existing product as well as the Sussa project. Adjusted EBITDA in the first quarter amounted to 58.2 (74.6) MSEK resulting in an adjusted EBITDA margin of 28.3 (36.1) %. Employee related expenses amounted to 111.6 (105.3) MSEK,